Galantamine (reminyl) for Alzheimer's disease.
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D003967:Diarrhea / Q000139:chemically induced; D004244:Dizziness / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D002800:Cholinesterase Inhibitors; D005702:Galantamine